Treace Medical Concepts (TMCI) Gross Profit (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Gross Profit data on file, last reported at $37.4 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 10.71% year-over-year to $37.4 million; the trailing twelve-month figure through Mar 2026 stood at $165.3 million (down 2.31% YoY), and the FY2025 full-year result was $169.8 million, up 0.88% from the prior year.
• Gross Profit for Q1 2026 stood at $37.4 million, down from $50.4 million in the prior quarter.
• Across five years, Gross Profit topped out at $55.5 million in Q4 2024 and bottomed at $23.9 million in Q1 2022.
• The 5-year median for Gross Profit is $37.4 million (2026), against an average of $37.9 million.
• The widest annual swing landed in 2022, when Gross Profit soared 55.51%; it then decreased 10.71% in 2026.
• A 5-year view of Gross Profit shows it stood at $40.7 million in 2022, then climbed by 24.53% to $50.7 million in 2023, then increased by 9.33% to $55.5 million in 2024, then decreased by 9.15% to $50.4 million in 2025, then decreased by 25.78% to $37.4 million in 2026.
• The last three Gross Profit figures came in at $37.4 million (Q1 2026), $50.4 million (Q4 2025), and $39.7 million (Q3 2025), per Business Quant data.

Peer Comparison